Show simple item record

dc.contributor.authorVijayakumar, Varun Kumar
dc.contributor.authorMustafa, Tehmina
dc.contributor.authorNore, Bjarte Kjell
dc.contributor.authorGaratun-Tjeldstø, Kjell Yngvar
dc.contributor.authorNæss, Øystein
dc.contributor.authorJohansen, Odd Erik
dc.contributor.authorAarli, Bernt Bøgvald
dc.date.accessioned2021-09-22T06:27:52Z
dc.date.available2021-09-22T06:27:52Z
dc.date.created2021-09-21T11:26:23Z
dc.date.issued2021
dc.identifier.issn1176-9106
dc.identifier.urihttps://hdl.handle.net/11250/2780207
dc.description.abstractBackground: The study investigated if a web-based clinical decision–support system (CDSS) tool would improve general practitioners’ (GPs) accuracy of diagnosis and classification of patients with chronic obstructive pulmonary disease (COPD), and whether nonpharmacological and pharmacological treatment would be better aligned with the COPD guidelines. Methods: GPs were randomized to either a single use of the CDSS or continuing standard of care. The clinical recommendations of the CDSS were based on the GOLD guidelines and provided suggestions for treatment and management of COPD. Data were collected digitally from GPs and patients in both groups using a tablet computer. A follow-up questionnaire was sent to the GPs 1 year after the conclusion of the study. Results: A total of 25 GPs (31% women, mean age 41 years) participated, 12 randomized to using the CDSS tool and 13 followed standard of care when assessing their next five to ten COPD patients. In sum, 149 patients with presumed COPD were included (88 CDSS group, 61 standard-of-care group). In the CDSS group, no COPD misdiagnoses occurred, 98% received vaccine recommendations, and all smokers (n=39) received smoking-cessation advice. The standard-of-care group had 23% misdiagnosis (P< 0.001), only 67% received vaccine recommendations (P< 0.001), and 87% smoking-cessation advice (P=0.022. All told, 31% of patients did not receive medication as recommended according to guidelines, with no significant differences between the groups. GPs rated the CDSS as very useful. Mean usage time was 3 minutes, 26 seconds. A majority (13 of 19, 68%) of the GPs continued using the CDSS after the conclusion of the study. CAT score identified twice as many patients as having more symptoms than the mMRC, indicating the added value of the multi-item questionnaire. Conclusion: Use of the CDSS was associated with preventing misdiagnosis of COPD and improved adherence to recommended nonpharmacological measures, but a single use did not improve pharmacological treatment considerations.en_US
dc.language.isoengen_US
dc.publisherDove Medical Pressen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleRole of a Digital Clinical Decision–Support System in General Practitioners’ Management of COPD in Norwayen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 Vijayakumar et al.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.2147/COPD.S319753
dc.identifier.cristin1936484
dc.source.journalThe International Journal of Chronic Obstructive Pulmonary Diseaseen_US
dc.source.pagenumber2327-2336en_US
dc.identifier.citationThe International Journal of Chronic Obstructive Pulmonary Disease. 2021, 16, 2327-2336.en_US
dc.source.volume16en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal